Published NeuroCuple® Clinical Study Shows Reduced Postoperative Pain and Opioid Use
Published Clinical Study Demonstrates Reduced Postoperative Pain and Opioid Use with NeuroCuple® Technology
A peer-reviewed clinical study published in the Journal of Clinical Medicine evaluated NeuroCuple® technology in total knee and hip arthroplasty patients, demonstrating meaningful reductions in postoperative pain and opioid prescription requests.
A Major Milestone in Drug-Free Pain Management Research
Postoperative pain management remains one of the largest challenges in orthopedic recovery. Patients undergoing total knee arthroplasty (TKA) and total hip arthroplasty (THA) frequently require substantial pain management support during rehabilitation and recovery.
Traditional recovery protocols often rely heavily on opioid medications. While opioids may provide short-term pain relief, healthcare systems worldwide continue searching for scalable alternatives that may reduce opioid exposure while still supporting recovery and mobility.
This peer-reviewed study published in the Journal of Clinical Medicine evaluated the NeuroCuple™ device as a non-pharmacological approach to postoperative pain management in orthopedic surgery patients. :contentReference[oaicite:0]{index=0}
Published Study Results
The prospective randomized study evaluated 69 patients undergoing unilateral primary total knee or hip arthroplasty. Patients received either standard postoperative care alone or standard care plus two NeuroCuple™ devices.
- 34% reduction in pain at rest during postoperative days 1–3
- 9% reduction in opioid consumption
- 52% reduction in opioid prescription requests following discharge
- Randomized prospective clinical trial design
- University of Pittsburgh Medical Center collaboration
- Published peer-reviewed orthopedic recovery research
Why These Findings Matter
Postoperative pain affects mobility, rehabilitation participation, recovery timelines, and overall patient outcomes.
One of the most important findings from this study was the substantial reduction in opioid prescription requests after hospital discharge. According to the published data, patients using NeuroCuple™ technology were significantly less likely to request opioid prescriptions following surgery. :contentReference[oaicite:2]{index=2}
This is particularly important because healthcare systems globally continue searching for scalable ways to reduce opioid exposure while supporting recovery and patient comfort.
Understanding NeuroCuple® Technology
NeuroCuple® technology represents an emerging category of passive bioelectrical interfaces designed to interact with the body's local bioelectrical environment without delivering powered electrical stimulation.
The Study Design
The study was conducted as a prospective randomized open-label clinical trial at UPMC Shadyside Hospital in Pittsburgh, Pennsylvania. Institutional review board approval was obtained before enrollment, and the study was registered on ClinicalTrials.gov (NCT05252858).
Patients undergoing unilateral total knee or total hip arthroplasty were randomized to receive either:
- Standard postoperative care alone
- Standard postoperative care plus NeuroCuple™ devices
Outcome measures included pain scores and opioid utilization during the postoperative recovery period.
Why This Research Extends Beyond Orthopedic Surgery
Pain-related disability remains one of the largest contributors to reduced participation, healthcare utilization, and lost productivity worldwide.
Technologies that may reduce pain while decreasing pharmaceutical burden could have implications far beyond a single surgical category.
Potential applications of scalable, reusable pain management technologies may include:
- Postoperative recovery programs
- Community-based pain support
- Low-resource healthcare environments
- Humanitarian healthcare deployment
- Population-scale pain management initiatives
- Distributed public health models
Published Clinical Evidence Continues to Expand
The Journal of Clinical Medicine publication represents an important milestone in the growing body of clinical evidence evaluating NeuroCuple® technology and passive bioelectrical pain management approaches.
Additional ongoing and recently published studies continue to evaluate postoperative pain management, opioid reduction, and broader applications of scalable non-drug pain management technologies.
Access the Full Published Study
The complete peer-reviewed publication is available through the Journal of Clinical Medicine and MDPI.